| Bioactivity | BRD-8000.3, as a specific EfpA inhibitor, is a narrow-spectrum, bactericidal antimycobacterial agent with good wild-type activity. BRD-8000.3 can be used for the research of tuberculosis[1]. | ||||||||||||
| Target | EfpA | ||||||||||||
| Invitro | BRD-8000.3, as a specific EfpA inhibitor, is a narrow-spectrum, bactericidal antimycobacterial agent with good wild-type activity[1]. | ||||||||||||
| Name | BRD-8000.3 | ||||||||||||
| CAS | 2365504-95-4 | ||||||||||||
| Formula | C19H21BrN4O | ||||||||||||
| Molar Mass | 401.30 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Johnson EO, et al. Large-Scale Chemical-Genetic Strategy Enables the Design of Antimicrobial Combination Chemotherapy in Mycobacteria. ACS Infect Dis. 2020;6(1):56-63. |
BRD-8000.3
CAS: 2365504-95-4 F: C19H21BrN4O W: 401.30
BRD-8000.3, as a specific EfpA inhibitor, is a narrow-spectrum, bactericidal antimycobacterial agent with good wild-type
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.